On the recordMay 9, 2023
I think it is clear that the lower price is not preferred.
Source
congress.govI think it is clear that the lower price is not preferred.
Kaine highlights the lack of preference for lower-priced insulin products in formularies.
Share
More from Tim Kaine
If you require them to pay fully up front and then get a rebate sometime down the road, you really jeopardize their operations.
I’m thrilled that $16 million is headed to the Virginia Advanced Pharma Manufacturing Cluster to support the domestic manufacturing of critical medicines, boost our supply chains, and grow our regional economy.
Everywhere we go throughout the Commonwealth, we hear the same thing: Virginians cannot afford this Administration’s disastrous policies.